CoChat

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population‐based study

Koloski, N. A., Jones, M., Young, M., Talley, N. J. · 2015 · Alimentary Pharmacology & Therapeutics
Cited by 60

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Summary: Background: While the Rome III classification recognises functional constipation (FC) and constipation predominant IBS (IBS‐C) as distinct disorders, recent evidence has suggested that these disorders are difficult to separate in clinical practice. Aim: To identify whether clinical and lifestyle factors differentiate Rome III‐defined IBS‐C from FC based on gastrointestinal symptoms and lifestyle characteristics. Method: 3260 people randomly selected from the Australian population returned a postal survey. FC and IBS‐C were defined according to Rome III. The first model used logistic regression to differentiate IBS‐C from FC based on lifestyle, quality‐of‐life and psychological characteristics. The second approach was data‐driven employing latent class analysis (LCA) to identify naturally occurring clusters in the data considering all symptoms involved in the Rome III criteria for IBS‐C and FC. Results: We found n = 206 (6.5%; 95% CI 5.7–7.4%) people met strict Rome III FC whereas n = 109 (3.5%; 95% CI 2.8–4.1%) met strict Rome III IBS‐C. The case–control approach indicated that FC patients reported an older age at onset of constipation, were less likely to exercise, had higher mental QoL and less health care seeking than IBS‐C. LCA yielded one latent class that was predominantly (75%) FC, while the other class was approximately half IBS‐C and half FC. The FC‐dominated latent class had clearly lower levels of symptoms used to classify IBS (pain‐related symptoms) and was more likely to be male (P = 0.046) but was otherwise similar in distribution of lifestyle factors to the mixed class. Conclusion: The latent class analysis approach suggests a differentiation based more on symptom severity rather than the Rome III view.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.13149

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Koloski, N. A., Jones, M., Young, M., & Talley, N. J.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2015-03-04
Volume
41
Issue
9
Pages
856-866
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2124623781
Cited by
60
References
7
FWCI
8.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.